CoChat

Cellular Catabolism of the Iron-Regulatory Peptide Hormone Hepcidin

Open access

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Hepcidin, a 25-amino acid peptide hormone, is the principal regulator of plasma iron concentrations. Hepcidin binding to its receptor, the iron exporter ferroportin, induces ferroportin internalization and degradation, thus blocking iron efflux from cells into plasma. The aim of this study was to characterize the fate of hepcidin after binding to ferroportin. We show that hepcidin is taken up by ferroportin-expressing cells in a temperature- and pH-dependent manner, and degraded together with its receptor. When Texas red-labeled hepcidin (TR-Hep) was added to ferroportin-GFP (Fpn-GFP) expressing cells, confocal microscopy showed co-localization of TR-Hep with Fpn-GFP. Using flow cytometry, we showed that the peptide was almost completely degraded by 24 h after its addition, but that lysosomal inhibitors completely prevented degradation of both ferroportin and hepcidin. In addition, using radio-labeled hepcidin and HPLC analysis we show that hepcidin is not recycled, and that only degradation products are released from the cells. Together these results show that the hormone hepcidin and its receptor ferroportin are internalized together and trafficked to lysosomes where both are degraded.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0058934

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Effect of temperature and pH on the uptake of 125I-hepcidin by cells expressing Fpn-GFP. ECR293cells were either not induced (-pon) or induced with ponasterone (+pon) to express Fpn-GFP. (A) Cells were incubated with 125I-hepcidin for 1 h at 0°C, 15°C, 23°C and 37°C, and the amount of radioactivity bound to cells was measured by gamma counting. *p<0.001, **p = 0.024 compared to uninduced cells at the same temperature. (B) Cells were incubated with 125I-hepcidin for 1 h at pH 2, 4, 5, 6, 7, 8 and 9, and the amount of radioactivity bound to cells was measured by gamma counter. Radioactivity in uninduced cells was subtracted as background. Because of the variation in absolute counts between separate experiments, data within each experiment were normalized to 125I-hepcidin uptake at pH 7. *p<0.01. All experiments were repeated a minimum of three times, and the error bars represent the standard deviation.
Figure 1 Effect of temperature and pH on the uptake of 125I-hepcidin by cells expressing Fpn-GFP. ECR293cells were either not induced (-pon) or induced with ponasterone (+pon) to express Fpn-GFP. (A) Cells were incubated with 125I-hepcidin for 1 h at 0°C, 15°C, 23°C and 37°C, and the amount of radioactivity bound to cells was measured by gamma counting. *p<0.001, **p = 0.024 compared to uninduced cells at the same temperature. (B) Cells were incubated with 125I-hepcidin for 1 h at pH 2, 4, 5, 6, 7, 8 and 9, and the amount of radioactivity bound to cells was measured by gamma counter. Radioactivity in uninduced cells was subtracted as background. Because of the variation in absolute counts between separate experiments, data within each experiment were normalized to 125I-hepcidin uptake at pH 7. *p<0.01. All experiments were repeated a minimum of three times, and the error bars represent the standard deviation.CC BY · PubMed Central
Figure 2 Hepcidin is co-internalized together with ferroportin. TR labeled hepcidin was added to cells expressing Fpn-GFP, and incubated at 37°C for 1 h protected from light. Cells were imaged by fluorescence confocal microscopy. Uninduced cells treated with TR hepcidin had no detectable red fluorescence (data not shown).
Figure 2 Hepcidin is co-internalized together with ferroportin. TR labeled hepcidin was added to cells expressing Fpn-GFP, and incubated at 37°C for 1 h protected from light. Cells were imaged by fluorescence confocal microscopy. Uninduced cells treated with TR hepcidin had no detectable red fluorescence (data not shown).CC BY · PubMed Central
Figure 3 Hepcidin is degraded together with ferroportin. ECR293cells were either not induced (-pon, dashed lines) or were induced with ponasterone to express Fpn-GFP (+pon, solid lines). Cells were treated with Texas Red-labeled hepcidin (TR-hepc) for 4 h, the peptide was then removed, and cells were incubated for another 20 h in the absence or presence of lysosomal inhibitors chloroquine (100 µM, green lines) or bafilomycin (100 nM, blue lines). Cells treated with hepcidin but not inhibitors are represented as black lines (no inh). The amount of cellular Fpn-GFP or Texas Red-hepcidin was determined by flow cytometry. Uninduced cells were used to establish a gate to exclude background fluorescence. (A) Quantitation of Fpn-GFP. Data are expressed relative to the green fluorescence of induced cells not treated with hepcidin. (B) Quantitation of Texas Red-hepcidin. Data are expressed relative to the red fluorescence of induced cells treated with Texas Red-hepcidin for 4 h.
Figure 3 Hepcidin is degraded together with ferroportin. ECR293cells were either not induced (-pon, dashed lines) or were induced with ponasterone to express Fpn-GFP (+pon, solid lines). Cells were treated with Texas Red-labeled hepcidin (TR-hepc) for 4 h, the peptide was then removed, and cells were incubated for another 20 h in the absence or presence of lysosomal inhibitors chloroquine (100 µM, green lines) or bafilomycin (100 nM, blue lines). Cells treated with hepcidin but not inhibitors are represented as black lines (no inh). The amount of cellular Fpn-GFP or Texas Red-hepcidin was determined by flow cytometry. Uninduced cells were used to establish a gate to exclude background fluorescence. (A) Quantitation of Fpn-GFP. Data are expressed relative to the green fluorescence of induced cells not treated with hepcidin. (B) Quantitation of Texas Red-hepcidin. Data are expressed relative to the red fluorescence of induced cells treated with Texas Red-hepcidin for 4 h.CC BY · PubMed Central
Figure 4 Hepcidin is not recycled. ECR293 cells were either not induced (-pon, dashed lines) or were induced with ponasterone to express Fpn-GFP (+pon, solid lines). 125I-hepcidin was added for 2 h to load the cells, excess hepcidin was washed off and fresh media added to the cells. Cell pellets and supernatants were collected after 5 min and 4, 8, and 24 h and radioactivity measured by gamma counting. (A) Counts in cell pellets. (B) Counts in supernatants. (C) and (D) Supernatants harvested at 5 min, 4, 8 and 24 h from uninduced and induced cells respectively were analyzed by reverse-phase HPLC using an acetonitrile gradient (1 fraction per minute). Radioactivity of each fraction was determined by gamma counting. Dashed vertical line indicates the elution fraction of native hepcidin.
Figure 4 Hepcidin is not recycled. ECR293 cells were either not induced (-pon, dashed lines) or were induced with ponasterone to express Fpn-GFP (+pon, solid lines). 125I-hepcidin was added for 2 h to load the cells, excess hepcidin was washed off and fresh media added to the cells. Cell pellets and supernatants were collected after 5 min and 4, 8, and 24 h and radioactivity measured by gamma counting. (A) Counts in cell pellets. (B) Counts in supernatants. (C) and (D) Supernatants harvested at 5 min, 4, 8 and 24 h from uninduced and induced cells respectively were analyzed by reverse-phase HPLC using an acetonitrile gradient (1 fraction per minute). Radioactivity of each fraction was determined by gamma counting. Dashed vertical line indicates the elution fraction of native hepcidin.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 2

  1. Park CH, Valore EV, Waring AJ, Ganz T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276: 7806– 7810. 11113131 · DOI · Paper page
  2. Clark RJ, Tan CC, Preza GC, Nemeth E, Ganz T, et al (2011) Understanding the structure/activity relationships of the iron regulatory peptide hepcidin. Chem Biol 18: 336– 343. 21439478 PMC3073735 · DOI · Paper page

Cited by

See all 56

Metadata

Authors
Preza, G. C., Pinon, R., Ganz, T., & Nemeth, E.
Affiliations
  • University of Southern California (US)
  • University of California, Los Angeles (US)
Corresponding author
Nemeth, Elizabeta
Venue
PLoS ONE
Published
2013-03-11
Volume
8
Issue
3
Pages
e58934
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1976587549
Cited by
56
References
23
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 1 · 2021: 4 · 2020: 6 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 10 · 2015: 8 · 2014: 7 · 2013: 3
FWCI
6.70
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK082717)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
Keywords
hepcidin, ferroportin, iron regulation, receptor internalization, lysosomal degradation, receptor recycling
MeSH terms
Ferroportin, Cell Line, Humans, Hydrogen-Ion Concentration, Iron, Lysosomes, Protein Binding, Temperature, Protein Transport, Cation Transport Proteins, Intracellular Space, Proteolysis, Hepcidins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.